Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Reiter

Showing results (161-170 of 239) with videos related to

Pageof 24
Sort By:
Cancers|November 11, 2022
TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of <i>BRCA2</i> Mutation StatusNajib Ben Khaled, Katharina Hammer, Liangtao Ye, et al.
International Journal of Molecular Sciences|November 18, 2020
IL-18 but Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver DiseaseSimon Hohenester, Veronika Kanitz, Tobias Schiergens, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2023
Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based studyNajib Ben Khaled, Bernhard Mörtl, Dominik Beier, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 18, 2025
Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis DToni Herta, Christopher Dietz-Fricke, Münevver Demir, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2023
Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based studyNajib Ben Khaled, Bernhard Mörtl, Dominik Beier, et al.
Hepatology (Baltimore, Md.)|March 13, 2024
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case seriesChristopher Dietz-Fricke, Elisabetta Degasperi, Mathias Jachs, et al.
Physical Review Letters|August 11, 2001
Magic nucleus 132Sn and its one-neutron-hole neighbor 131SnP Bhattacharyya, P J Daly, C T Zhang, et al.
Therapeutic Advances in Medical Oncology|October 27, 2025
Treatment gaps and survival outcomes of hepatocellular carcinoma: insights from a nationwide, claims-based studySimone Schrodi, Karin Berger-Thürmel, Selina Becht, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 1, 2020
Liver Transplantation for Acute Intermittent PorphyriaMattias Lissing, Greg Nowak, René Adam, et al.
Journal of Hepatology|May 23, 2017
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitisPeter Fickert, Gideon M Hirschfield, Gerald Denk, et al.
Pageof 24

Showing results (161-170 of 239) with videos related to

Sort By:
Pageof 24
Cancers|November 11, 2022
TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of <i>BRCA2</i> Mutation StatusNajib Ben Khaled, Katharina Hammer, Liangtao Ye, et al.
International Journal of Molecular Sciences|November 18, 2020
IL-18 but Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver DiseaseSimon Hohenester, Veronika Kanitz, Tobias Schiergens, et al.
European Journal of Cancer (Oxford, England : 1990)|December 30, 2023
Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based studyNajib Ben Khaled, Bernhard Mörtl, Dominik Beier, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 18, 2025
Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis DToni Herta, Christopher Dietz-Fricke, Münevver Demir, et al.
European Journal of Cancer (Oxford, England : 1990)|September 6, 2023
Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based studyNajib Ben Khaled, Bernhard Mörtl, Dominik Beier, et al.
Hepatology (Baltimore, Md.)|March 13, 2024
Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case seriesChristopher Dietz-Fricke, Elisabetta Degasperi, Mathias Jachs, et al.
Physical Review Letters|August 11, 2001
Magic nucleus 132Sn and its one-neutron-hole neighbor 131SnP Bhattacharyya, P J Daly, C T Zhang, et al.
Therapeutic Advances in Medical Oncology|October 27, 2025
Treatment gaps and survival outcomes of hepatocellular carcinoma: insights from a nationwide, claims-based studySimone Schrodi, Karin Berger-Thürmel, Selina Becht, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 1, 2020
Liver Transplantation for Acute Intermittent PorphyriaMattias Lissing, Greg Nowak, René Adam, et al.
Journal of Hepatology|May 23, 2017
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitisPeter Fickert, Gideon M Hirschfield, Gerald Denk, et al.
Pageof 24